| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,418 |
13,491 |
$247K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,269 |
5,181 |
$112K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,827 |
4,298 |
$108K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,196 |
1,016 |
$56K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,843 |
2,507 |
$44K |
| G0378 |
Hospital observation service, per hour |
984 |
759 |
$42K |
| 80053 |
Comprehensive metabolic panel |
16,608 |
13,629 |
$36K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,919 |
1,203 |
$34K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,007 |
5,749 |
$25K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,551 |
2,325 |
$24K |
| 70450 |
Computed tomography, head or brain; without contrast material |
917 |
746 |
$18K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,316 |
3,113 |
$17K |
| 71046 |
Radiologic examination, chest; 2 views |
2,907 |
2,622 |
$17K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,707 |
4,069 |
$15K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,619 |
1,863 |
$14K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
17,698 |
14,392 |
$14K |
| 90686 |
|
1,704 |
1,629 |
$13K |
| 90715 |
|
1,085 |
1,013 |
$11K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,627 |
2,119 |
$11K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,764 |
1,596 |
$11K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,881 |
1,769 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
24,967 |
20,622 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
988 |
927 |
$9K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,413 |
2,471 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,381 |
3,620 |
$8K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
888 |
707 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,849 |
3,195 |
$8K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,157 |
2,628 |
$7K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,109 |
348 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,496 |
1,416 |
$7K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,848 |
1,361 |
$6K |
| 81001 |
|
4,367 |
3,735 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,389 |
6,961 |
$6K |
| 80061 |
Lipid panel |
4,229 |
4,074 |
$5K |
| 86140 |
|
2,616 |
2,163 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,418 |
4,226 |
$5K |
| 87081 |
|
1,076 |
1,035 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,684 |
1,950 |
$5K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,376 |
3,319 |
$5K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
584 |
555 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,522 |
2,110 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,618 |
2,853 |
$4K |
| 84439 |
|
2,052 |
1,941 |
$4K |
| 81025 |
|
2,759 |
2,395 |
$4K |
| 87186 |
|
1,030 |
898 |
$3K |
| 83690 |
|
2,841 |
2,405 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
4,493 |
3,199 |
$3K |
| 87420 |
|
247 |
232 |
$3K |
| 90651 |
|
18 |
17 |
$3K |
| 83605 |
|
2,489 |
1,842 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,667 |
2,278 |
$3K |
| 83655 |
|
357 |
346 |
$3K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
659 |
560 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
591 |
553 |
$3K |
| 73562 |
|
430 |
324 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,659 |
1,591 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
3,286 |
2,531 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
607 |
568 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
66 |
65 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,399 |
1,602 |
$2K |
| 90656 |
|
116 |
115 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,051 |
999 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
411 |
302 |
$1K |
| 91320 |
|
51 |
51 |
$1K |
| 84703 |
|
1,024 |
921 |
$1K |
| 81003 |
|
1,903 |
1,685 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
3,238 |
2,490 |
$1K |
| 84484 |
|
2,429 |
1,661 |
$1K |
| 82728 |
|
281 |
251 |
$992.83 |
| 85651 |
|
593 |
498 |
$981.26 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
555 |
465 |
$943.00 |
| 73030 |
|
228 |
174 |
$903.97 |
| 87077 |
|
1,058 |
931 |
$802.17 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,420 |
929 |
$792.06 |
| 73610 |
|
144 |
125 |
$777.99 |
| 85018 |
|
612 |
559 |
$743.11 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,965 |
2,958 |
$699.15 |
| 85379 |
|
572 |
491 |
$678.10 |
| 85027 |
|
1,603 |
1,435 |
$605.55 |
| 90480 |
|
34 |
34 |
$585.87 |
| 83540 |
|
303 |
283 |
$575.00 |
| J3490 |
Unclassified drugs |
1,175 |
944 |
$562.78 |
| 83735 |
|
2,136 |
1,583 |
$558.60 |
| 90670 |
|
14 |
14 |
$554.22 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,819 |
1,830 |
$550.01 |
| 80305 |
|
350 |
278 |
$523.24 |
| 73110 |
|
77 |
62 |
$487.47 |
| 71045 |
Radiologic examination, chest; single view |
555 |
436 |
$481.92 |
| 81002 |
|
1,835 |
1,633 |
$440.61 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
249 |
172 |
$414.98 |
| 80178 |
|
133 |
116 |
$400.55 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,617 |
2,153 |
$375.64 |
| 36416 |
|
146 |
141 |
$332.66 |
| 85610 |
|
2,923 |
2,016 |
$325.07 |
| 73630 |
|
60 |
51 |
$313.82 |
| 80076 |
|
65 |
58 |
$312.38 |
| 83550 |
|
158 |
149 |
$278.79 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
84 |
80 |
$274.38 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
675 |
604 |
$268.50 |
| 96376 |
|
43 |
38 |
$236.12 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,587 |
1,294 |
$209.38 |
| 90682 |
|
257 |
253 |
$166.74 |
| 87070 |
|
47 |
42 |
$161.33 |
| 83615 |
|
194 |
153 |
$158.51 |
| 91322 |
|
47 |
44 |
$146.63 |
| 97161 |
|
14 |
13 |
$133.55 |
| 87040 |
|
19 |
14 |
$130.48 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,196 |
695 |
$104.65 |
| 87807 |
|
20 |
19 |
$103.27 |
| 99152 |
|
37 |
24 |
$72.41 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
404 |
363 |
$68.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
186 |
141 |
$67.15 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
45 |
42 |
$65.53 |
| 87147 |
|
13 |
13 |
$63.56 |
| G0008 |
Administration of influenza virus vaccine |
139 |
135 |
$45.30 |
| 82570 |
|
180 |
170 |
$45.22 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
269 |
196 |
$42.30 |
| 87205 |
|
15 |
14 |
$42.24 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
496 |
364 |
$33.40 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
171 |
140 |
$29.50 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
84 |
62 |
$9.45 |
| 82607 |
|
32 |
27 |
$0.00 |
| A9270 |
Non-covered item or service |
1,456 |
451 |
$0.00 |
| 86901 |
|
449 |
376 |
$0.00 |
| 86850 |
|
632 |
545 |
$0.00 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
150 |
41 |
$0.00 |
| 97162 |
|
129 |
111 |
$0.00 |
| 82077 |
|
22 |
15 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17 |
16 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
51 |
41 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
83 |
76 |
$0.00 |
| 90732 |
|
13 |
13 |
$0.00 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
163 |
55 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
65 |
64 |
$0.00 |
| 82043 |
|
83 |
81 |
$0.00 |
| 82962 |
|
206 |
150 |
$0.00 |
| 83880 |
|
83 |
52 |
$0.00 |
| 73502 |
|
18 |
12 |
$0.00 |
| Q3014 |
Telehealth originating site facility fee |
28 |
26 |
$0.00 |
| 82550 |
|
33 |
24 |
$0.00 |
| 90673 |
|
12 |
12 |
$0.00 |
| 90677 |
|
28 |
27 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
15 |
12 |
$0.00 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
15 |
12 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
14 |
13 |
$0.00 |
| 86703 |
|
409 |
390 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
95 |
88 |
$0.00 |
| 84100 |
|
95 |
56 |
$0.00 |
| 72100 |
|
57 |
51 |
$0.00 |
| 86900 |
|
440 |
363 |
$0.00 |
| 94729 |
|
13 |
13 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,061 |
685 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
48 |
44 |
$0.00 |
| 72110 |
|
101 |
88 |
$0.00 |
| 82977 |
|
70 |
52 |
$0.00 |
| 99442 |
|
30 |
30 |
$0.00 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12 |
12 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
57 |
49 |
$0.00 |
| 90662 |
|
23 |
23 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
50 |
41 |
$0.00 |
| 76942 |
|
16 |
12 |
$0.00 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
55 |
47 |
$0.00 |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
16 |
12 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
14 |
14 |
$0.00 |
| 82248 |
|
12 |
12 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
39 |
37 |
$0.00 |
| 59025 |
Fetal non-stress test |
12 |
12 |
$0.00 |
| 36600 |
|
28 |
27 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
13 |
12 |
$0.00 |
| 94726 |
|
13 |
13 |
$0.00 |